Oxaliplatin, isovorin (IV) and 5-fluorouracil (5FU) as second-third line treatment in advanced colorectal carcinoma (ACC).

被引：0
|
作者：
de Castro, J [1 ]
Feliu, J [1 ]
Casado, E [1 ]
de Paredes, MLG [1 ]
Espinosa, E [1 ]
Zamora, P [1 ]
de las Heras, B [1 ]
Jiménez, A [1 ]
Ordóñez, A [1 ]
Barón, MG [1 ]
机构：
[1] Univ Autonoma Madrid, Hosp La Paz, S Oncol Med, E-28049 Madrid, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] Third line oxaliplatin with leucovorin (LV) and continuous infusion 5-fluorouracil (5FU) in metastatic colorectal cancer.
    Abón, G
    Muñoz, A
    Rubio, I
    Mañé, JM
    Ferreiro, J
    Fernández, R
    Fuente, N
    López-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 48 - 49
  • [2] Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)
    Punt, CJA
    Keizer, HJ
    Douma, J
    Schüller, J
    Skovsgaard, T
    ten Napel, CHH
    Lochs, H
    Muller, EW
    Russell, L
    Wagener, DJT
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
  • [3] Pharmacogenetic approach for capecitabine or 5-fluorouracil (5FU) selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer
    Martinez-Balibrea, E.
    Abad, A.
    Aranda, E.
    Sastre, J.
    Manzano, J. L.
    Aparicio, J.
    Garca, T.
    Maestu, I.
    Martinez-Cardus, A.
    Gines, A.
    Guino, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] PHARMACOKINETICS AND PHARMACODYNAMICS OF LOCOREGIONAL 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL LIVER METASTASES
    GOLDBERG, JA
    KERR, DJ
    WILLMOTT, N
    MCKILLOP, JH
    MCARDLE, CS
    BRITISH JOURNAL OF CANCER, 1988, 57 (02) : 186 - 189
  • [5] Oxaliplatin (L-OHP) plus levo-folinic acid (I-FA) and 5-fluorouracil (5FU)-FOLFOX2 regimen in second-third-line chemotherapy (CT) of advanced colorectal cancer (ACC).
    Luppi, G
    Zanelli, F
    Lombardo, L
    Giannetta, L
    ANNALS OF ONCOLOGY, 2000, 11 : 48 - 48
  • [6] Second and third-line chemotherapy (CT) with oxaliplatin L-OHP), 5-fluorouracil (FU) and leucovorin (LV) in patients (pts) with advanced colorectal cancer (ACC): a new schedule.
    D'Andrea, M
    Bari, M
    Sartori, D
    Silvestri, B
    Azzarello, G
    Rosetti, F
    Zardo, S
    Porcellini, A
    Vinante, O
    ANNALS OF ONCOLOGY, 2000, 11 : 49 - 49
  • [7] Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer
    Novarino, Anna
    Satolli, Maria Antonietta
    Chiappino, Isabella
    Giacobino, Alice
    Bellone, Graziella
    Rahimi, Farnaz
    Milanesi, Enrica
    Bertetto, Oscar
    Ciuffreda, Libero
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 44 - 48
  • [8] TREATMENT OF ADVANCED CARCINOMA OF PROSTATE WITH ESTRAMUSTINE AND 5-FLUOROURACIL(FU)
    KENNEALEY, GT
    MARSH, JC
    WELCH, DA
    IAMKIS, MD
    GILL, GM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 394 - 394
  • [9] A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma
    Gennatas, C.
    Papaxoinis, G.
    Michalaki, V.
    Mouratidou, D.
    Andreadis, Ch.
    Tsavaris, N.
    Pafiti, A.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (05) : 538 - 544
  • [10] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
12345